The Roth Capital Partners Conference will take place February 18-21 at the Ritz Carlton Hotel, Laguna Niguel, CA. Donald M. Earhart, I-Flow's Chairman, President, and Chief Executive Officer will make a presentation featuring the Company's growth strategies and market opportunities.

I-Flow Corporation is an emerging leader in post-surgical pain relief and is redefining recovery following surgery. The Company's flagship ON-Q® PainBuster® Post-Op Pain Relief System provides targeted pain relief after surgery only where the body needs it, automatically delivering a non-narcotic, pain-numbing medication directly to an incision site for up to five days. The anesthetic is administered through a specially-designed, proprietary catheter -- like the ON-Q SilverSoaker^TM which offers enhanced antimicrobial properties to reduce the risk of infection by providing an added layer of protection -- inserted by a surgeon during surgery. ON-Q PainBuster is cleared for use by the U.S. Food & Drug Administration (FDA) and is labeled to reduce pain significantly better than narcotics and to significantly reduce narcotics intake after surgery. Additionally, evidence is mounting that ON-Q PainBuster, by documenting an infection reduction capability, may be a broader surgical site care device. Hospitals saw infection rates more than halved in a new study that was recently announced.

You can access a live webcast and slides of the presentation, after registration, from the Investors link or the Investors' Event Calendar link at www.IFLO.com. The webcast will be available for replay at approximately 9:10 a.m. EST at this same internet address for approximately 90 days. Audio streams require Windows Media Player installations.

About I-Flow

I-Flow Corporation (www.IFLO.com) designs, develops and markets technically advanced, low cost drug delivery systems and services that are redefining the standard of care by providing life enhancing, cost effective solutions for pain relief.